Clinical Trials Logo

Filter by:
NCT ID: NCT02760082 Recruiting - Multiple Sclerosis Clinical Trials

Motivation of Patients Diagnosed With Multiple Sclerosis to Become Citizen Researchers

Start date: February 2016
Phase: N/A
Study type: Observational

The study will based on qualitative methods investigate motivational factors among patients diagnosed with multiple sclerosis for registering nutrition, environmental factors, stress provoking factors and physical activity (NESPA). The aim is to gain knowledge on motivational factors for using a digital tool for collecting data on NESPA and incorporate this knowledge into a form which can be used in requirement specifications for such a digital tool.

NCT ID: NCT02755675 Recruiting - Clinical trials for Non-small Cell Lung Cancer

uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung

Start date: April 2016
Phase: Phase 2
Study type: Interventional

uPAR PET/CT as a prognostic marker in non-small cell lung cancer.

NCT ID: NCT02746562 Recruiting - Infertility Clinical Trials

Study Comparing Outcomes Between Conventional IVF and a "Freeze-all"-Strategy in Assisted Reproductive Technology

Start date: May 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to compare conventional fresh embryo transfer with a "freeze all and transfer later strategy" in assisted reproductive technology in terms of ongoing pregnancy rates, live birth rates as well as perinatal outcomes.

NCT ID: NCT02732990 Recruiting - Clinical trials for Chronic Heart Failure

Peripheral Metabolic Function in Chronic Heart Failure Patients

Start date: February 2014
Phase: N/A
Study type: Interventional

Exercise intolerance is a major limiting symptom in patients with CHF. However the poor correlation between the hemodynamic parameters of left ventricular performance at rest and exercise performance has led to the concept that peripheral factors such as muscle perfusion and muscle metabolism play a role as determinants of exercise capacity.

NCT ID: NCT02727296 Recruiting - Clinical trials for Delayed Graft Function

Volatile Anesthetic Protection Of Renal Transplants 2

VAPOR-2
Start date: April 1, 2017
Phase: Phase 4
Study type: Interventional

To compare the effect of a sevoflurane based anesthesia versus a propofol based anesthesia on the incidence of DGF in recipients of kidneys of donation after circulatory death (DCD) and donation after brain death (DBD) donors

NCT ID: NCT02715284 Recruiting - Neoplasms Clinical Trials

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

GARNET
Start date: March 7, 2016
Phase: Phase 1
Study type: Interventional

This is a multi-center, open-label, first-in-human Phase 1 study evaluating the anti-programmed death receptor 1 (anti-PD-1) antibody dostarlimab (also known as TSR-042) n participants with advanced solid tumors who have limited available treatment options. The study will be conducted in 2 parts with Part 1 consisting of safety evaluation, pharmacokinetics (PK), and pharmacodynamics (PDy) of escalating doses of dostarlimab. Dose escalation will be based on ascending weight-based dose levels (DLs) of dostarlimab and will continue until the maximum tolerated dose (MTD) is reached or may be stopped at any dose level up to the highest dose of 20 milligrams per kilograms (mg/kg) based on emerging safety and PK/PDy data. Part 2 will be conducted in two subparts, Part 2A (fixed-dose safety evaluation cohorts) and Part 2B (expansion cohorts). Part 2A of the study will evaluate the safety and tolerability of dostarlimab at fixed doses of 500 mg administered every 3 weeks (Q3W) and 1000 mg administered every 6 weeks (Q6W). Part 2B of the study will examine the safety and clinical activity of dostarlimab in cohorts of participants with specific types of advanced solid tumors.

NCT ID: NCT02709460 Recruiting - Clinical trials for Postoperative Hemorrhage

Lateral Occlusion of Uterine Artery in Total Laparoscopic Hysterectomy

Start date: January 2016
Phase: N/A
Study type: Interventional

Laparoscopic hysterectomy is associated with complications in form of infections and subsequently dehiscence of the vault. This is a serious complication. The infection may be related to the frequently observed postoperative hematoma following traditional laparoscopic hysterectomy where the uterine artery is coagulated and divided at the cervical entry into the uterus. By coagulation of the uterine artery laterally close to the internal iliac artery this problem may be eliminated due to the much less bleeding observed during this procedure.

NCT ID: NCT02708979 Recruiting - Stress Clinical Trials

Stress and Eating Behavior Among University Students - an Randomized Controlled Trial

StrEat
Start date: February 2016
Phase: N/A
Study type: Interventional

The high worldwide prevalence of overweight and obesity as well as metabolic and disease consequences, are well-documented. The positive energy balance underlying obesity is attributable to excess energy intake and/or insufficient energy expenditure. However, it seems that the increase in mean body weight can be sufficiently explained by increases in mean energy intake. It has been proposed that this overeating is partly caused by increased availability of highly processed energy dense, high reward foods. Psychosocial stress and sleep insufficiency is pervasive in industrialized societies. A growing body of evidence suggests stress to be involved in obesity, although it is unknown whether stress is a cause or consequence. Stress affecting dietary intake; skewing intake towards greater consumption of highly palatable energy dense foods, also referred to as high reward foods. A causal relationship between stress and reward seeking behavior is supported by findings from animal studies reporting rewarding behavior by consumption of sweet tasting food in response to a stressor. Our aim is to investigate differences in purchases of particular food-items in free living individuals, during a stressful (upcoming exam) and non-stressful (no upcoming exam) period. Hypothesis: Participants will purchase more high reward foods during the pre-exam period, compared to the control non-exam period.

NCT ID: NCT02693587 Recruiting - Safety Clinical Trials

Misodel or Angusta for Induction of Labour?

Start date: November 2015
Phase: N/A
Study type: Observational [Patient Registry]

In Denmark, every 4 birth induced, most often due to prolonged pregnancy, up til 10-12 days after term. A group (RADS) set up by the Danish Regions has recently recommended induction with prostaglandins in tablet form (Angusta®). The recommendation is based primarily on the results of a meta-analysis published by the Cochrane Library, where various prostaglandin medications were compared. Vaginal prostaglandin insert (Misodel®) have proved safe in American Studies and is registered in Denmark for use of induction. Misodel® was not included in RADS's evaluation, as there are only few studies on the effectiveness and side effects. In the current study, investigators want to compare two different regimes for the induction of primipara who use respectively Misodel® and Angusta® as the primary method. The study is based on prospective collection of data from three divisions in Region Zealand, where investigators primarily compare the efficacy and safety but also to evaluate women's experience, the cost of medicine and consumption of resources in the maternity wards.

NCT ID: NCT02686775 Recruiting - Lung Cancer Clinical Trials

The PACO Project: A Clinical Study of a PAtient COach Program in Vulnerable Lung Cancer Patients

PACO
Start date: January 2016
Phase: N/A
Study type: Interventional

The randomized trial evaluates whether assigning a patient coach to vulnerable lung cancer patients will empower these patients to participate in the treatment decision process, help patients navigate the health care system while undergoing treatment and adhere to cancer treatment and to recommendations for supportive care. Half of the participants will receive standard care and be offered a patient coach while the other half will receive standard care.